DonnaPrzepiorkaMD

PubMed

• 8 citations
  FDA Approval Summary: Brexucabtagene Autoleucel for Treatment of Adults With Relapsed or Refractory B-Cell Precursor Acute Lymphoblastic Leukemia.
  Najat Bouchkouj, Xue Lin, Xiaofei Wang, Donna Przepiorka, Zhenzhen Xu, Tejashri Purohit-Sheth, Marc Theoret> ;The Oncologist. 2022 Oct 1
• 5 citations
  FDA Approval Summary: Oral Azacitidine for Continued Treatment of Adults with Acute Myeloid Leukemia Unable to Complete Intensive Curative Therapy.
  Emily Y Jen, Xin Wang, Meng Li, Hongshan Li, Shwu-Luan Lee, Nina Ni, Donna Przepiorka, Jonathon Vallejo, Ruby Leong, Lian Ma, Brenda J Gehrke, Sherita McLamore, Marc R...> ;Clinical Cancer Research. 2022 Jul 15
• 8 citations
  FDA Approval Summary: Belumosudil for Adult and Pediatric Patients 12 Years and Older with Chronic GvHD after Two or More Prior Lines of Systemic Therapy.
  Donna Przepiorka, Robert Q Le, Alexei Ionan, Ruo-Jing Li, Ying-Hong Wang, Ramadevi Gudi, Soumya Mitra, Jonathon Vallejo, Olanrewaju O Okusanya, Lian Ma, Yuching Yang, ...> ;Clinical Cancer Research. 2022 Jun 13
• 1 citations
  FDA Approval Summary: Ruxolitinib for Treatment of Chronic Graft-Versus-Host Disease after Failure of One or Two Lines of Systemic Therapy.
  Robert Q Le, Xin Wang, Hongfei Zhang, Hongshan Li, Donna Przepiorka, Jonathon Vallejo, Ruby Leong, Lian Ma, Kirsten B Goldberg, Richard Pazdur, Marc R Theoret, Angelo ...> ;The Oncologist. 2022 Jun 8
• Using marginal structural models to analyze the impact of subsequent therapy on the treatment effect in survival data: Simulations and clinical trial examples.
  Qing Xu, Donna Przepiorka> ;Pharmaceutical Statistics. 2021 Apr 27
• 1 citations
  The Role of Acute Myeloid Leukemia Minimal Residual Disease in Regulatory Decision-making.
  Donna Przepiorka, R. Angelo de Claro, Richard Pazdur> ;JAMA Oncology. 2021 May 1
• 31 citations
  FDA Approval Summary: Gilteritinib for Relapsed or Refractory Acute Myeloid Leukemia with a FLT3 Mutation
  E. Dianne Pulte, Kelly J. Norsworthy, Yaping Wang, Qing Xu, Hisham Qosa, Ramadevi Gudi, Donna Przepiorka, Wentao Fu, Olanrewaju O. Okusanya, Kirsten B. Goldberg, R. An...> ;Clinical Cancer Research. 2021 Feb 25
• 45 citations
  Differentiation Syndrome with Ivosidenib and Enasidenib Treatment in Patients with Relapsed or Refractory IDH-Mutated AML: A U.S. Food and Drug Administration Systemat...
  Kelly J. Norsworthy, Flora Mulkey, Emma C. Scott, Ashley F. Ward, Donna Przepiorka, Rosane Charlab, Sarah E. Dorff, Albert Deisseroth, Dickran Kazandjian, Rajeshwari S...> ;Clinical Cancer Research. 2020 Aug 15
• 38 citations
  Idelalisib for Treatment of Relapsed Follicular Lymphoma and Chronic Lymphocytic Leukemia: A Comparison of Treatment Outcomes in Clinical Trial Participants vs Medicar...
  Steven T. Bird, Fang Tian, Natasha Flowers, Donna Przepiorka, Rongrong Wang, Tae-Hyun Jung, Zebulin Kessler, Corinne Woods, Bo Kim, Barry W. Miller, Michael Wernecke, ...> ;JAMA Oncology. 2020 Feb 1
• 34 citations
  FDA Approval Summary: Ruxolitinib for Treatment of Steroid-Refractory Acute Graft-Versus-Host Disease.
  Donna Przepiorka, Lola Luo, Sriram Subramaniam, Junshan Qiu, Ramadevi Gudi, Lea C Cunningham, Lei Nie, Ruby Leong, Lian Ma, Christopher Sheth, Albert Deisseroth, Kirst...> ;The Oncologist. 2020 Feb 1
• 51 citations
  FDA Approval Summary: Tagraxofusp-erzs For Treatment of Blastic Plasmacytoid Dendritic Cell Neoplasm.
  Emily Y. Jen, Xin Gao, Liang Li, Luning Zhuang, Natalie Simpson, Baikuntha Aryal, Rong Wang, Donna Przepiorka, Yuan Li Shen, Ruby Leong, Chao Liu, Christopher M. Sheth...> ;Clinical Cancer Research. 2020 Feb 1
• 22 citations
  FDA Approval Summary: Calaspargase Pegol-mknl For Treatment of Acute Lymphoblastic Leukemia in Children and Young Adults
  Ruo-Jing Li, Runyan Jin, Chao Liu, Xianhua Cao, Michael L. Manning, Xu Michael Di, Donna Przepiorka, Frances Namuswe, Albert Deisseroth, Kirsten B. Goldberg, Gideon M....> ;Clinical Cancer Research. 2020 Jan 15
• 75 citations
  FDA Approval Summary: Ivosidenib for relapsed or refractory acute myeloid leukemia with an isocitrate dehydrogenase-1 mutation
  Kelly J. Norsworthy, Lola Luo, Vicky Hsu, Ramadevi Gudi, Sarah E. Dorff, Donna Przepiorka, Albert Deisseroth, Yuan Li Shen, Christopher M. Sheth, Rosane Charlab, Gene ...> ;Clinical Cancer Research. 2019 Jun 1
• 153 citations
  FDA Approval Summary: (Daunorubicin and Cytarabine) Liposome for Injection for the Treatment of Adults with High-Risk Acute Myeloid Leukemia.
  Aviva C Krauss, Xin Gao, Liang Li, Michael L. Manning, Paresma Patel, Wentao Fu, Kumar G. Janoria, Gerlie Gieser, David A. Bateman, Donna Przepiorka, Yuan Li Shen, Sta...> ;Clinical Cancer Research. 2019 May 1
• 137 citations
  FDA Approval Summary: Tisagenlecleucel for Treatment of Patients with Relapsed or Refractory B-Cell Precursor Acute Lymphoblastic Leukemia
  Maura C. O'Leary, Xiaobin Lu, Ying Huang, Xue Lin, Iftekhar Mahmood, Donna Przepiorka, Denise Gavin, Shiowjen Lee, Ke Liu, Bindu George, Wilson Bryan, Marc R. Theoret,...> ;Clinical Cancer Research. 2019 Feb 15
• 83 citations
  FDA Approval: Blinatumomab for Patients with B-cell Precursor Acute Lymphoblastic Leukemia in Morphologic Remission with Minimal Residual Disease
  Emily Y. Jen, Qing Xu, Aaron J. Schetter, Donna Przepiorka, Yuan Li Shen, Donna Roscoe, Rajeshwari Sridhara, Albert Deisseroth, Reena Philip, Ann T. Farrell, Richard P...> ;Clinical Cancer Research. 2019 Jan 15
• 73 citations
  FDA Approval Summary: Glasdegib for newly-diagnosed acute myeloid leukemia
  Kelly J. Norsworthy, Kunthel By, Sriram Subramaniam, Luning Zhuang, Pedro L. Del Valle, Donna Przepiorka, Yuan Li Shen, Christopher M. Sheth, Chao Liu, Ruby Leong, Kir...> ;Clinical Cancer Research. 2019 May 7
• 27 citations
  FDA Approval Summary: Midostaurin for the Treatment of Advanced Systemic Mastocytosis
  Yvette L. Kasamon, Chia-Wen Ko, Sriram Subramaniam, Lian Ma, Yuching Yang, Lei Nie, Stacy S. Shord, Donna Przepiorka, Ann T. Farrell, Amy E. McKee, Richard Pazdur> ;The Oncologist. 2018 Dec 1
• 9 citations
  Weighty choices: selecting optimal G-CSF doses for stem cell mobilization to optimize yield.
  Nosha Farhadfar, Jack W. Hsu, Brent R. Logan, Jennifer A. Sees, Pintip Chitphakdithai, Michele W. Sugrue, Hisham Abdel-Azim, Paolo Anderlini, Christopher Bredeson, Sau...> ;Blood Advances. 2018 Nov 29
• 32 citations
  FDA Supplemental Approval: Blinatumomab for Treatment of Relapsed and Refractory Precursor B-Cell Acute Lymphoblastic Leukemia.
  E. Dianne Pulte, Jonathon Vallejo, Donna Przepiorka, Lei Nie, Ann T. Farrell, Kirsten B. Goldberg, Amy E. McKee, Richard Pazdur> ;The Oncologist. 2018 Nov 1
• 5 citations
  Upper Gastrointestinal Acute Graft- versus-host Disease Adds Minimal Prognostic Value in Isolation or With Other Graft- versus-host Disease Symptoms as Currently Diagn...
  Sarah Nikiforow, Tao Wang, Michael T. Hemmer, Stephen R. Spellman, Gorgun Akpek, Joseph H. Antin, Sung Won Choi, Yoshihiro Inamoto, Hanna Jean Khoury, Margaret L. MacM...> ;Haematologica. 2018 Oct 1
• 138 citations
  FDA Approval Summary: Mylotarg for Treatment of Patients with Relapsed or Refractory CD33‐Positive Acute Myeloid Leukemia
  Kelly J. Norsworthy, Chia-Wen Ko, Jee Eun Lee, Jiang Liu, Christy S. John, Donna Przepiorka, Ann T. Farrell, Richard Pazdur> ;The Oncologist. 2018 Sep 1
• 508 citations
  FDA Approval Summary: Tocilizumab for Treatment of Chimeric Antigen Receptor T Cell‐Induced Severe or Life‐Threatening Cytokine Release Syndrome
  Robert Q. Le, Liang Li, Weishi Yuan, Stacy S. Shord, Lei Nie, Bahru A. Habtemariam, Donna Przepiorka, Ann T. Farrell, Richard Pazdur> ;The Oncologist. 2018 Aug 1
• Determination of Similarity Margin in Comparative Clinical Studies to Support the Development of Biosimilar Products of Neupogen ® (Filgrastim, Granulocyte Colony-Stim...
  Lei Nie, Donna Przepiorka, Albert Deisseroth, Rajeshwari Sridhara, Thomas E. Gwise> ;Biodrugs. 2018 Jul 13
• 121 citations
  FDA Approval: Gemtuzumab Ozogamicin for the Treatment of Adults with Newly Diagnosed CD33-Positive Acute Myeloid Leukemia
  Emily Y. Jen, Chia-Wen Ko, Jee Eun Lee, Pedro L. Del Valle, Antonina G. Aydanian, Charles Jewell, Kelly J. Norsworthy, Donna Przepiorka, Lei Nie, Jiang Liu, Christophe...> ;Clinical Cancer Research. 2018 Feb 23
• Join now to see all